drug
Loseasonique
Marketedupdated 3mo agoby Teva Pharmaceuticals USA Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 5, 2028
~2.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Dec 5, 2028method-of-use (U-1)US 78551902.3y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 44m ago
Found something off?
comments(0)
5-min edit window · permanent after that